Skip to main content

Table 7 Variables associated with and independent predictors of low adiponectin serum levels (<6 μg/ml) in 261 CHC patients

From: The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls

Adiponectin

Low (n = 72)

High (n = 189)

p

OR * (95% c.i.)

p *

Steatosis present

59 (82)

120 (63)

0.004

3.85 (1.78-8.91)

0.0005

Age (years)

51±14

61±13

<0.0001

0.95 (0.92-0.97)

<0.0001

Sex (F)

10 (14)

100 (53)

<0.0001

0.18 (0.08-0.38)

<0.0001

HDL (mg/dl)

42±11

53±17

<0.0001

-

-

Triglycerides (mg/dl)

121±71

98±38

0.012

-

-

Cirrhosis

15 (21)

65 (34)

0.036

0.65 (0.30-1.40)

0.277

Viral genotype 4

11 (15)

8 (4)

0.0055

1.68 (0.55-5.70)

0.456

ADIPOQ

     

rs2241766TT and rs1501299T+

26 (36)

92 (49)

0.068

0.74 (0.39-1.40)

0.355

rs2241766G + or rs1501299GG

46 (64)

97 (51)

 

reference

 

PNPLA3 rs738409

     

CC (148 I/I)

34 (47)

99 (52)

0.73

1.15 (0.71-2.80)

0.600

CG (148 I/M)

30 (42)

73 (39)

   

GG (148 M/M)

8 (11)

17 (9)

   
  1. ():% values; * OR of low adiponectin values at logistic regression analysis considering as independent variables the presence or not of NAFLD, age, gender, BMI, ALT, and ADIPOQ and PNPLA3 genotype (additive model; OR per number of 148 M alleles).